Alkyltransferase-like proteins (ATLs) share functional motifs with the cancer chemotherapy target O 6 -alkylguanine-DNA alkyltransferase (AGT) and paradoxically protect cells from the biological effects of DNA alkylation damage, despite lacking the reactive cysteine and alkyltransferase activity of AGT. Here we determine Schizosaccharomyces pombe ATL structures without and with damaged DNA containing the endogenous lesion O 6 -methylguanine or cigarette-smoke-derived O 6 -4-(3-pyridyl)-4-oxobutylguanine. These results reveal non-enzymatic DNA nucleotide flipping plus increased DNA distortion and binding pocket size compared to AGT. Our analysis of lesion-binding site conservation identifies new ATLs in sea anemone and ancestral archaea, indicating that ATL interactions are ancestral to present-day repair pathways in all domains of life. Genetic connections to mammalian XPG (also known as ERCC5) and ERCC1 in S. pombe homologues Rad13 and Swi10 and biochemical interactions with Escherichia coli UvrA and UvrC combined with structural results reveal that ATLs sculpt alkylated DNA to create a genetic and structural intersection of base damage processing with nucleotide excision repair.
-alkylguanine lesions are mutagenic and cytotoxic: they mispair during replication with thymine, resulting in GNC to ANT transition mutations [1] [2] [3] [4] . Human O . This prevents mutations, but also provides resistance against alkylating chemotherapies 2, 5 . The active site PCHRV sequence motif Cys 145 (refs 6, 7) plus Arg 128 and Tyr 114 nucleotide rotating residues are conserved from bacterial to human AGTs 1,2, 8 . Human AGT structures alone 9, 10 and with small molecule 9 or DNA 11, 12 substrates showed how AGT promotes resistance to anticancer therapies by directly reversing DNA guanine alkylation damage 2 . Recently, bacterial and yeast proteins with sequence similarity to the AGT DNA-binding domain were identified in which the cysteine alkyl acceptor was replaced by tryptophan, alanine or another residue 13 , and hence named alkyltransferase-like proteins (ATLs). ATLs from S. pombe (Atl1) and E. coli (eAtl) inhibit O 6 -methylguanine (O 6 -mG) repair by human AGT 14, 15 . E. coli Atl also binds abasicsite-containing double-stranded (ds)DNA 16 , and Atl1 binds single-stranded (ss)DNA containing O 6 -methyl-, O 6 -benzyl-, O 6 -(4-bromothenyl)-or O 6 -hydroxyethyl-guanine. However, ATLs do not cleave the alkyl group, base or oligonucleotide near the lesion 14, 15 , and the E. coli Atl Trp-to-Cys mutation does not restore alkyltransferase activity 14 . Because S. pombe and Thermus thermophilus lack AGT, and inactivation of their ATL genes (atl1 and TTHA1564, respectively 15, 17 ) reduces their alkylation damage resistance, ATLs protect against biological effects of DNA alkylation damage by an undefined mechanism.
Tight binding affinities for 16, 17 and inability to repair 14, 15 O 6 -alkyl lesions implied ATLs are damage sensors or act in nucleotide excision repair (NER) 13, 15 , which excises bulky, DNA-distorting lesions. However, the lack of structures, persuasive evidence or a specific mechanism has obscured how ATL ameliorates DNA damage effects. To clarify this protection, we combined structural, biochemical and genetic experiments on Atl1 from the fission yeast S. pombe. Our results reveal that ATL binding generates a stable complex that sculpts alkylated DNA base damage for NER pathway entry.
Atl1 structure and lesion binding
To characterize Atl1-DNA damage interactions, we crystallized and solved structures to 2.0, 2.7 and 2.8 Å resolution, respectively, for Atl1 alone ( Fig. 1a and 18 . Atl1 shares the human AGT catalytic domain fold (superposition root mean squares difference of 1.6 Å ; Fig. 1a ), including residues required for AGT activity, DNA binding and nucleotide flipping. Yet, Atl1 specifically lacks the active site Cys and Asn hinge of AGT that couples helix-turn-helix DNA binding and active site motifs (Fig. 1a) .
Atl1 flips both O 6 -mG (Fig. 1b, d ) and O 6 -pobG (Fig. 1c) into a pocket containing PWHRV sequence motif Trp 56, consistent with fluorescence-measured flipping for a base opposite an AP site in E. coli Atl (ref. 16 ) and for O 6 -mG in TTHA1564 (ref. 17) . Atl1 displays no AGT activity 15 , indicating that nucleotide flipping is a switch for pathway activation, not catalysis. To our knowledge, Atl1 (Fig. 1b-d ), E. coli Atl (ref. 16 ) and TTHA1564 (ref. 17) are among the first reported non-enzymatic DNA-binding proteins that flip nucleotides. Our Atl1 structures show that ATL rotates nucleotides into a specificity pocket. Arg 39 intercalates the DNA base stack (Fig. 1d ) and hydrogen bonds with the orphaned cytosine, thereby stabilizing the extra-helical alkylguanine. Trp 56, rather than AGT Cys, is evident in electron density omit maps (Fig. 1a) and acts in hydrophobic packing with the alkyl group (Fig. 1c, d ). Arg 69 guanidinium stacks against the alkylguanine base in a cation-p interaction (Fig. 1d) .
Alkylguanine base side and main chain hydrogen bonds are conserved from Atl1 to AGT, but the Atl1 lesion-binding pocket is approximately three times larger (Supplementary Table 2 ). Loop residues 65-73 define one wall of the alkyl-binding pocket, adopting a conformation further from the protein core than in AGT, thereby enlarging the pocket (Figs 1a and 2a) . Also, the lesion-binding pocket Lys 45-Pro 55 cap is ,5.3 Å further out than the comparable AGT Pro 140 (Ca to Ca distance), which interacts with larger alkyl groups 9, 11, 12 . Moreover, ATL Ile 71 replaces AGT Tyr 158, which would clash with the Atl1 Trp 56 side chain in its DNA-bound, closed position.
The larger cavity of Atl1 explains its broad lesion range, which includes O 6 -benzyl-, O 6 -(4-bromothenyl)-or O 6 -hydroxyethylguanine. In the O 6 -pobG-DNA complex structure, the pob group is wedged between Pro 50 and Trp 56, making only these hydrophobic protein interactions (Fig. 1c) and need for ATLs for bulky adducts in organisms such as E. coli.
DNA binding by Atl1
Like AGT, Atl1 uses a helix-turn-helix motif to bind the DNA minor groove (Figs 1b and 2a) . All damaged-strand contacts are to alkylguanine and two 39-adjacent nucleotide phosphate groups (Fig. 2d) . DNA binding site loop (Ser 67 and Lys 70) and C-terminal loop (Thr 92 and Ser 93) residues form DNA contacts not found in AGT. DNA binding of Atl1 buries ,1,050 Å 2 versus 788 Å 2 of AGT buried surface area, consistent with tighter DNA binding 16, 17 . Atl1 bends DNA by ,45u (Fig. 2a) , whereas AGT only bends DNA by ,30u (ref. 11). Atl1 achieves greater DNA bending through synergistic amino terminus and binding site loop actions. The Atl1 N-terminal helix extends outward more than the corresponding AGT helix, which follows a loop leading towards the N-terminal domain (Figs 1a and 2a) . This N-terminal extension pushes against the phosphate backbone of the complementary strand opposite the flipped nucleotide. Moreover, the binding site loop acts as a gate that switches between 'open' (Fig. 2b ) and 'closed' (Fig. 2c) conformations of free and DNA-bound Atl1, respectively, with flanking glycines suggesting flexibility. This 'gating' action was proposed in AGT computational simulations 21 but was not seen in crystal structures 11, 12 . The Atl1 binding site loop open-to-closed conformational switch appears suitable to have an active role in signalling by shifting covering Arg and Ile side chains to expose the C-terminal loop for possible intermolecular interactions.
If the closed, bent ATL-DNA complex is a platform for repair protein recognition, then we expect the complex to be stable; however, K d was estimated by gel-shift assays to be only 0. 41 -pobG. Thus, whereas 'on' rates were similar for both lesions, the 'off' rate for the pob oligonucleotide was slower: higher affinity (K d ) for the pob oligonucleotide shows larger O 6 -alkyl groups are accommodated stably.
We also measured Atl1 binding to methylated double-stranded oligonucleotides by gel-shift assays ( Fig. 3b and Supplementary Fig. 1 Connections of Atl1 to nucleotide excision repair ATLs tightly bind oligonucleotides containing O 6 -alkylguanine and switch conformation to expose the C-terminal loop, indicating that ATL-DNA complex binding partners are possible, in vivo. In fact, the NER protein UvrA interacts with TTHA1564 (ref. 17) . Similarly, farwestern analysis reveals that E. coli Atl interacts with E. coli NER proteins UvrA and UvrC in vitro (Fig. 4a) . E. coli DNA repair helicase IV (HelD) is also a potential E. coli Atl binding partner 16 . Interestingly, S. pombe Atl1 interacts with E. coli UvrA in vitro (Fig. 4b) , indicating that ATLs conserve features across species for NER recognition.
To test for Atl1 functional genetic interactions with the NER pathway in fission yeast, we analysed S. pombe atl1 and rad13 (NER pathway XPG endonuclease human homologue that cuts 39 of DNA lesions 23 ) single and double deletants. We measured the ability of Atl1 to protect cells from N-methyl-N9-nitro-N-nitrosoguanidine (MNNG)-induced and spontaneous mutations (Fig. 4c-e) . MNNG sensitivity of Datl1 cells was complemented by a plasmid harbouring atl1 (Supplementary Fig. 2 ), indicating that observed cellular phenotypes are due to atl1 deletion. Atl1 inactivation causes approximately ninefold increased reversion rate of the ade6-485 mutation, similar to the Drad13 mutant (Fig. 4c, top) . The MNNG-induced mutation rate is not further increased in the Datl1 Drad13 double mutant, revealing an epistatic relationship between Atl1 and Rad13 (Fig. 4c, top) . These results are supported by spot tests (Fig. 4d ) and clonogenic assays (Fig. 4e) , indicating Atl1 and Rad13 are also epistatic for MNNG toxicity.
Strikingly, the increased spontaneous mutation rate of Drad13 cells is suppressed to wild-type levels by additional Atl1 inactivation (Fig. 4c, bottom) . This effect is not due to decreased cell survival, because all mutants tested here are viable (Supplementary Fig. 3 ). Clonogenic assays also revealed that Atl1 is epistatic with S. pombe Swi10 (Fig. 4f ), but not Rhp14 (Fig. 4g) or Rad2 ( Fig. 4h ; homologues of human ERCC1, XPA and FEN1, respectively), for MNNG toxicity. The non-epistatic relationship between Atl1 and Rhp14 indicates that Rhp14 has an NER-independent function in response to MNNG, consistent with Rhp14 responses to other DNA-damaging agents (R.K. and O.F., unpublished data). Because Rad2 has a role in long-patch base excision repair (BER) 24 and the alternative ultraviolet excision repair 25 , lack of epistasis between atl1 and rad2 implies the two proteins work in different pathways. Rad13 and swi10 mutant phenotypes may reflect build-up of stable hard-to-repair ATLcomplex intermediates in the absence of these NER proteins, indicating that ATL-DNA complexes may block alternative repair. Similarly, Atl1 protects E. coli cells against MNNG-induced alkylation damage (Supplementary Table 4 ). Thus, both microbial and eukaryotic genetic evidence indicates that ATL bridges DNAalkylation base damage responses to NER.
Identification of novel ATLs
To see whether our structures may characterize other ATLs, we mapped sequence conservation of 197 ATL sequences based on the Atl1 structure (Supplementary Figs 4 and 5) . For all ATLs, the most conserved residues line the lesion-binding pocket or act in DNA binding in our structures, suggesting that our Atl1 structures are paradigmatic for ATLs.
Significantly, our structure-based sequence analyses helped us to identify here the first ATL from any multicellular organism, the recently sequenced starlet sea anemone Nematostella vectensis 26 plus two archaeal ATLs from Candidatus Korarchaeum cryptofilum 27 and Nanoarchaeum equitans 28 , ancestral to the two established phyla of archaea (GenBank accession numbers XM_001618690, YP_001736655 and NP_963633, respectively; Supplementary Figs 4 and 6). We verified that N. vectensis ATL blocks the alkyltransferase activity of human AGT ( Supplementary Fig. 7 ), confirming it is an ATL. The N. vectensis genome, which aided in genome characterization of the long-extinct last common ancestor of all eumetazoans, is surprisingly more similar to vertebrates than to fruitflies or nematodes 26 . Therefore, existence of ATL in this multicellular eukaryote, plus yeast, bacteria and ancestral archaea, shows that ATL is present in all three domains of life and argues that ATL was common to evolutionary branches before complex eukaryotes. This discovery suggests that complex eukaryotes and mammals will either have an ATL or have lost or replaced it with an analogous protein. MNNG. e-h, Clonogenic assay, revealing that atl1 is epistatic for MNNG toxicity with rad13 (e) and swi10 (f), but not rhp14 (g) or rad2 (h). Results shown are mean 6 s.e.m.; n $ 3.
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ARTICLES Discussion Alkylated DNA base damage is classically repaired by direct damage reversal proteins or by lesion-specific DNA glycosylases, which excise modified bases to create abasic sites and initiate the BER pathway 29 . These base repair processes differ from the versatile NER removal of bulky, unrelated, helix-distorting lesions by excising a lesioncontaining DNA patch 30 . Our combined results reveal a general mechanism for ATL to bind weakly distorting O 6 -alkylguanine lesions and recruit NER proteins (Fig. 5) . We propose that ATL binding sculpts alkylguanine into a bulky lesion that is channelled into the NER pathway, explaining NER-mediated repair of O 6 -alkylguanine lesions [31] [32] [33] . ATL may be an unrecognized NER element, with analogues in many organisms, that targets endogenous alkylation damage to NER nucleases. In complex eukaryotes, the NER transcriptioncoupled repair (TCR) sub-pathway engages downstream damage recognition components of global genome repair (GGR), to effect lesion removal from the transcribed strand 34 . The NER GGR subpathway is initiated by XPC recognition of bulky lesions and, like TCR, results in damage removal by incision on either side of the lesion 35 . Because the O 6 -mG lesion is insufficient to block transcription 36 , ATL binding may stall RNA polymerase to initiate TCR and/or promote lesion processing analogously to DDB2 of mammalian GGR. Atl1-DNA contacts are with the damaged strand, similar to DDB2 (ref. ATLs are not alkyltransferases 14, 15, 17 or glycosylases 14, 15 , but inhibit AGT 14, 15 ( Supplementary Fig. 7 ). Lack of epistasis for MNNGinduced cell killing between atl1 and rad2 shows that ATL is not a long-patch BER or alternative ultraviolet excision repair protein. Yet, ATL damage recognition resembles that of AGT and BER glycosylases rather than that of NER proteins. It uses a positively charged channel for lesion-binding and 180u nucleotide flipping, which allow protein handoffs without release of toxic and mutagenic DNA intermediates, a hallmark of BER and recombination repair pathways [39] [40] [41] [42] [43] . ATL binding targets base damage to NER, showing how proteins that bind damage, but do not repair it, may redirect lesion processing 44 . First, ATL binds base damage analogously to AGT and BER glycosylases 2, 45 , but presents damage to NER similarly to DDB2. Second, in some organisms ATL can block AGT O 6 -alkylguanine damage recognition and redirect base repair to NER, constituting a crosstalk pathway connection 44 , as proposed for AGT 33, 46 and recently for E. coli Atl 20 . Third, ATL redirects endogenous damage from other repair pathways to NER, because the Drad13 mutator is rescued in Datl1 Drad13 mutants. Fourth, ancestral archaeal ATLs are ATL-Endo V fusions, suggesting that ATL and Endo V act together in a coordinated pathway 47 , with the BER nuclease Endo V serving a possible XPG-like function in these organisms, as AGT-Endo V fusion proteins retain both activities 48 . By the Rosetta Stone evolution hypothesis for protein interactions 47 , ATL-Endo V fusions imply that ATL provides a primordial connection joining BER and NER. Indeed, recent structures of Endo V (ref. 49 ) and NER complex DDB1-DDB2 (ref. 37 ) support such an ancient BER-NER connection by revealing a mutual, wedge-based binding mechanism 50 . Thus, non-enzymatic nucleotide flipping emerges as a surprisingly general mechanism to channel specific base damage into the general damage NER pathway by handoff from a non-enzymatic complex.
METHODS SUMMARY
Atl1 purification, crystallization, X-ray diffraction data collection and structural refinement. C-terminally 63 His-tagged Atl1 was expressed in JM109 cells and purified over Ni-NTA agarose and Superdex 75 columns. Atl1-O 6 -mG-and Atl1-O 6 -pobG DNA complexes were prepared at a 1.5:1 DNA:protein molar ratio. Crystals were grown by hanging-drop vapour diffusion. Diffraction data were collected at ALS beamline 12.3.1 for Atl1 and at SSRL beamline 11-1 for Atl1-O 6 -mG and Atl1-O 6 -pobG DNA complexes, and were processed with HKL2000. Structures were solved by molecular replacement with Phaser, using a modified wild-type Ada-C (PDB accession code 1SFE) as a search model for Atl1, and the refined Atl1 structure as a search model for Atl1-DNA complexes. Crystallographic refinement was done with Crystallography & NMR System (CNS), and Xfit was used for manual model building. DNA binding by Atl1. Oligonucleotide-Atl1 interactions were analysed by an electrophoretic mobility shift assay using standard methods and by surface plasmon resonance with biotinylated O 6 -mG-, O
6
-pobG-or AP-site-containing or control oligonucleotides immobilized on a streptavidin-coated surface of a BioRad NLC chip and serial dilutions of Atl1 applied to the cell. DNA complex stoichiometries formed under protein saturation conditions were established by sedimentation equilibrium analysis. Other biochemical assays. AGT inhibition assays were performed as described previously. Far western analyses were performed using standard methods. Atl1 expression in S. pombe. S. pombe strains originated from GM4 (h 2 atl1::ura4 ura4-D18 leu1-32 his7-366 ade6-M210) or RO131 (h 1 rad13::kanMX ura4-D18 his3-D1). MNNG sensitivity was determined by agar plate and clonogenic assays. Mutation rates were determined as reversions of ade6-485 to Ade 
